Scaffolds, Stem Cells, and Tissues. Oh, My!
A primer for how the FDA regulates stem cells
A primer for how the FDA regulates stem cells
Johnny Franco, MD, FACS, discusses how implant removals, biologic innovation, and patient demand for long-term tissue health are accelerating a regenerative shift in body aesthetics.
A new study reveals nearly 10% of surgeons leave clinical practice within eight years, with plastic and reconstructive surgery facing a 19.3% attrition rate.